Sarepta Therapeutics, Inc.
SRPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$180 | $197 | -$448 | $159 |
| Dep. & Amort. | $12 | $11 | $10 | $10 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $37 | $41 | $50 |
| Change in WC | $0 | $50 | -$282 | -$125 |
| Other Non-Cash | $168 | -$33 | $94 | -$2 |
| Operating Cash Flow | $0 | $261 | -$583 | $92 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$32 | -$44 | -$38 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $241 | -$286 | -$163 |
| Inv. Sales/Matur. | $0 | $69 | $41 | $965 |
| Other Inv. Act. | $0 | -$246 | -$2 | $0 |
| Investing Cash Flow | $0 | $32 | -$291 | $764 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | $0 | $0 |
| Stock Issued | $0 | $2 | $0 | $0 |
| Stock Repurch. | $0 | -$25 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $12 | $49 |
| Financing Cash Flow | $0 | -$24 | $12 | $49 |
| Forex Effect | $102 | $0 | $0 | $0 |
| Net Chg. in Cash | $102 | $270 | -$862 | $905 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $511 | $256 | $1,119 | $213 |
| End Cash | $613 | $526 | $256 | $1,119 |
| Free Cash Flow | $0 | $232 | -$629 | $54 |